NEW YORK (360Dx) – Mologic today announced its rapid point-of-care test for bacterial vaginosis has received CE marking.

The firm also is commercially launching the test called BVPro and has inked a three-year distribution deal with Sysmex subsidiary Hitado to distribute the test throughout Germany. Mologic did not disclose the terms of the agreement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.